
Company valuation, historical trends, and peer comparisons.
According to Cassava Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -55048883.00. This represents a change of 554.44% compared to the average of -8411540.00 of the last 4 quarters.
The mean historical Enterprise Value of Cassava Sciences, Inc. over the last ten years is -36138153.53. The current -55048883.00 Enterprise Value has changed 52.33% with respect to the historical average. Over the past ten years (40 quarters), SAVA's Enterprise Value was at its highest in in the September 2020 quarter at 27.43M. The Enterprise Value was at its lowest in in the March 2021 quarter at -204566950.00.
Average
-36138153.53
Median
-18424567.65
Minimum
-152420750.00
Maximum
12.70M
Discovering the peaks and valleys of Cassava Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 507.51%
Maximum Annual Enterprise Value = 12.70M
Minimum Annual Increase = -412.49%
Minimum Annual Enterprise Value = -152420750.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 3.51M | -110.44% |
| 2024 | -33599550.00 | -4.48% |
| 2023 | -35175400.00 | -70.31% |
| 2022 | -118461900.00 | -22.28% |
| 2021 | -152420750.00 | 283.95% |
| 2020 | -39697750.00 | -412.49% |
| 2019 | 12.70M | 507.51% |
| 2018 | 2.09M | -28.43% |
| 2017 | 2.92M | -189.91% |
| 2016 | -3249585.30 | -81.84% |
The current Enterprise Value of Cassava Sciences, Inc. (SAVA) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-21756033.33
5-year avg
-67230150.00
10-year avg
-36138153.53
Cassava Sciences, Inc.’s Enterprise Value is less than Annovis Bio, Inc. (32.91M), less than Anavex Life Sciences Corp. (-1527979.00), less than Axsome Therapeutics, Inc. (7.11B), less than Bionano Genomics, Inc. (16.99M), less than Iovance Biotherapeutics, Inc. (3.88B), less than Novavax, Inc. (1.86B), less than Ocugen, Inc. (358.74M), less than Vaxart, Inc. (54.01M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 32.91M | $51.64M | |
| -1527979.00 | $116.80M | |
| 7.11B | $7.21B | |
| 16.99M | $14.01M | |
| 3.88B | $3.94B | |
| 1.86B | $1.76B | |
| 358.74M | $296.55M | |
| 54.01M | $97.13M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cassava Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cassava Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cassava Sciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Cassava Sciences, Inc. (SAVA)?
What is the 3-year average Enterprise Value for Cassava Sciences, Inc. (SAVA)?
What is the 5-year average Enterprise Value for Cassava Sciences, Inc. (SAVA)?
How does the current Enterprise Value for Cassava Sciences, Inc. (SAVA) compare to its historical average?